Back
Zimmer Biomet Holdings Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
38
ZBH
Zimmer Biomet Holdings
Last Price:
103.52
Seasonality Move:
3.39%
Sell
17
ASND
Ascendis Pharma AS
Last Price:
128.92
Seasonality Move:
11.38%
Sell
38
Zimmer Biomet Holdings (ZBH)
is a Sell
Is Zimmer Biomet Holdings a Buy, Sell or Hold?
- The current Zimmer Biomet Holdings [ZBH] share price is $103.50. The Score for ZBH is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ZBH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $128.87. The Score for ASND is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ZBH Stock Price Chart
What is Zimmer Biomet Holdings's stock price today?
-
The Zimmer Biomet Holdings share price today is $103.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZBH is experiencing selling pressure, which indicates risk of future bearish movement.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $128.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
ZBH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.54 | Sell |
| Relative Strength Index (14 RSI): | 40.14 | Sell |
| Chaikin Money Flow: | -709618 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.79 | Sell |
| Relative Strength Index (14 RSI): | 39.56 | Sell |
| Chaikin Money Flow: | -398802 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (124.63 - 149.99) | Sell |
| Bollinger Bands (100): | (126.12 - 142.4) | Sell |
ZBH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 103.55 | Sell |
| 20-day SMA: | 105.71 | Sell |
| 50-day SMA: | 108.27 | Sell |
| 200-day SMA: | 116.66 | Sell |
| 8-day EMA: | 103.82 | Sell |
| 20-day EMA: | 105.38 | Sell |
| 50-day EMA: | 107.56 | Sell |
| 200-day EMA: | 113.81 | Sell |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 136.2 | Sell |
| 20-day SMA: | 142.75 | Sell |
| 50-day SMA: | 135.11 | Sell |
| 200-day SMA: | 137.7 | Sell |
| 8-day EMA: | 134.74 | Sell |
| 20-day EMA: | 137.46 | Sell |
| 50-day EMA: | 136.41 | Sell |
| 200-day EMA: | 131.41 | Sell |
Zimmer Biomet Holdings Earnings Growth & ZBH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.60 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.71 per share, and an increase next year of $4.17 per share.
Zimmer Biomet Holdings Technical Analysis
| Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 30 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 30 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||